Peptide Decoding
New?New to peptides?Start here →
Decoding

Oligopeptide-24 (CG-EDP3)_Dosage, benefits & legal status

Also known as CG-EDP3, CMYIEGGGGRGDG, oligopeptide 24

Published November 17, 2026

An EGF fragment and an integrin motif, joined by a four-glycine hinge.

Skin appearanceCosmetic tridecapeptide (topical)Cosmetic
DoseSet by the finished product
FrequencyDaily, as directed by the product
RouteOn the skin (topical)
StatusCosmetic ingredient
CycledNot cycled

See how this dose compares across the library →

01

What is Oligopeptide-24 (CG-EDP3)?

Plain language first. The technical label stays, but it never stands alone.

Overview

A topical peptide built from a small piece of EGF joined to the grip sequence cells use to hold on.

The technical version

Oligopeptide-24 is a cosmetic tridecapeptide, CMYIEGGGGRGDG, combining epidermal growth factor residues 20 to 24 with an RGD integrin-binding motif on a tetraglycine linker.

What it's used for

A topical peptide in skin-repair formulas, built from an EGF fragment and a cell-adhesion motif.

02

How does Oligopeptide-24 (CG-EDP3) work?

What it does in the body, and where.

Oligopeptide-24 is CMYIEGGGGRGDG. Read it in three pieces and the design is obvious, which is unusual for a cosmetic peptide.

  1. 01
    CMYIE is a real piece of EGF
    Epidermal growth factor is 53 residues, and this site's oligopeptide-1 card carries the full sequence. Residues 20 through 24 of it are CMYIE, which is exactly how this peptide starts. So the EGF-like description has a specific basis, not a vague one.
  2. 02
    RGD at the other end is a different mechanism entirely
    Arginine-glycine-aspartate is the canonical motif that integrins recognize, the handhold cells use to attach to the matrix around them. It is found in fibronectin and is one of the most studied three-residue sequences in biology. It has nothing to do with EGF signaling.
  3. 03
    The four glycines in between are a hinge
    GGGG is a flexible spacer. Its job is to keep the two ends far enough apart that each can do its own thing, which is a standard way of building a two-function peptide.
  4. 04
    What the design does not tell you
    A five-residue fragment of a growth factor is not the growth factor. EGF works by binding its receptor with a folded 53-residue structure held together by disulfide bonds, and five residues of it cannot reproduce that. The honest reading is a plausible two-part design with no published human evidence.
Anatomical illustration highlighting skin
WHERE THIS COMPOUND IS THOUGHT TO ACT:
Skin

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Skin conditioning, the function the cosmetic ingredient inventory assigns itnone
  • Skin repair, which supplier and reagent descriptions claimnone
  • Standing in for epidermal growth factor in a formula, which the EGF-like framing implies and no study supportsnone

The published record

Research index

0

Papers about Oligopeptide-24 (CG-EDP3) · this compound only

Searched: Oligopeptide-24, CG-EDP3, 1018685-16-9, CMYIEGGGGRGDG.

Europe PMC was searched on November 18, 2026 for these terms and returned nothing.

Counted from Europe PMC indexing, not read by a person.

Oligopeptide-24 (CG-EDP3) vial rendering
Compound field notes

At a glance

Four things to know about Oligopeptide-24 (CG-EDP3)

01

Evidence

Cosmetic

02

Category

Skin and cosmetic

03

Common vial

Varies

04

Half-life

Not measured, and not the right question

04

How much, and do you cycle it?

The range, and whether you take breaks.

Set by the finished product, daily, as directed by the product. Not cycled Community practice

Used daily as part of a routine. Nothing about it suggests tolerance or a need for a break, and nothing has been studied that would show either way.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not measured, and not the right questionNo figure

No half-life has been published for this peptide. It is applied to the skin in a finished cosmetic rather than dosed into the bloodstream, so a circulating half-life would not describe anything useful. What matters for a topical is penetration and persistence in the tissue, and that has not been published here.

You can compare this against the whole library to see where it sits.

06

How is it given?

Dosing context and source notes.
No draw available

Supplied as a ready-made solution, so there is nothing to mix.

No trial or label gives a dose for this peptide, so none is stated here. It is applied as a topical product at whatever concentration the manufacturer sets, and no supplier use level was found in anything read at source. The one published paper measures the peptide in finished creams rather than recommending an amount.

07

How do you store it?

Before mixing, and after.

Room temperature, out of light. Cap it tight after each use.

Oligopeptide-24 (CG-EDP3) ships as a cream, gel, or serum. Keep it at room temperature away from sun and heat unless the label says otherwise. Refrigerating an emulsion can split the texture. Watch for color, smell, or separation changes and stop using it if any appear.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 38% charged residues, 23% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • A known allergy to this ingredient or to others in the same product
  • Broken, cracked, or actively irritated skin
  • Anyone who wants published human efficacy evidence, because none was found for this peptide

Stop and get help

These are emergencies. Seek care.
  • A rash that spreads beyond where you applied it
  • Swelling of the face, lips, or eyelids, or any trouble breathing
  • Burning that does not settle after rinsing it off

Common effects

Expected, and usually mild.
  • No adverse effects are reported for this peptide and no published testing has looked for them. Irritation from a product containing it may come from anything else in the formula.

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Oligopeptide-24 (CG-EDP3) approved?

And where the numbers on this page come from.

Not as a medicine. Oligopeptide-24 (CG-EDP3) is sold without a prescription as a cosmetic ingredient, which is a different thing from being approved as a drug.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

  • MedChemExpress, Oligopeptide-24 product data sheet(2026)
    The reference data behind the identity, and the reason this card can state a sequence at all. CAS 1018685-16-9, molecular formula C50H78N16O19S2, molecular weight 1271.38, and the sequence Cys-Met-Tyr-Ile-Glu-Gly-Gly-Gly-Gly-Arg-Gly-Asp-Gly, shortened CMYIEGGGGRGDG. Described as a bioactive peptide with a skin repair effect reported as a cosmetic ingredient.
  • SpecialChem cosmetics INCI directory, Oligopeptide-24(2021)
    The cosmetic ingredient inventory entry, which corroborates the sequence from a different direction. It describes Oligopeptide-24 as a synthetic peptide containing thirteen amino acids consisting of arginine, aspartic acid, cysteine, isoleucine, glutamic acid, glycine, methionine and tyrosine, carries reference number 83566, assigns the function skin conditioning, and names CG-EDP3 as the commercial grade. Those eight amino acids are exactly the set that appears in CMYIEGGGGRGDG, which is a real check rather than a restatement.
  • Giannakou, Varvaresou, Kiriazopoulos, Papageorgiou, Kavvalou, Tsirivas and Panderi, Quantification of oligopeptide-20 and oligopeptide-24 in cosmetic creams using hydrophilic interaction liquid chromatography with electrospray ionization mass spectrometry, Separation Science Plus 1(3):159-167(2018)
    The only published paper located on this peptide, and it is worth being precise about what it is. Published in Separation Science Plus, volume 1, issue 3, 2018, pages 159 to 167, digital object identifier 10.1002/sscp.201800016, by seven authors from a Greek cosmetic science department. It develops and validates a method for quantifying oligopeptide-20 and oligopeptide-24 in cosmetic creams by hydrophilic interaction liquid chromatography with electrospray ionization mass spectrometry, and the authors describe it as the first reported application of that technique to the simultaneous determination of the two peptides, usable for routine quality control. It establishes the peptide as a measurable analyte in a finished product. It is not a clinical study and makes no efficacy claim. Not read at source: the publisher's page could not be opened here, so the title, authors, journal, volume, pages, digital object identifier and the authors' own summary of their contribution come from bibliographic records rather than from the article itself, and the abstract was not read in full.